Red Ace Bio

THERAtRAME

The company develops small molecule inhibitors targeting tRNA epitranscriptomics to treat resistant and immune-refractory cancers for patients with limited therapeutic options.

Transforming cells into cures

This company develops a cellular engineering platform to design and optimize cell therapies for biopharmaceutical developers and research institutions.

Red Queen Bio

This company develops AI-powered antibody drugs and medical countermeasures against biological threats for governments, biopharma organisations and frontier artificial intelligence laboratories.

Replace Therapeutics

The company develops genome editing technology to insert and delete small DNA sequences for biotechnology firms and healthcare researchers.

Immitra Bio

This company develops an in-vivo gene editing platform to provide off-the-shelf curative treatments for patients with rare genetic diseases.

Cassidy Bio

This company develops an AI foundation model to design gene editing therapies and prediction tools for pharmaceutical partners and researchers.

OverT Bio

This company develops engineered cell therapies and genetic screening platforms to treat patients with solid tumour cancers.

Resurrect Bio

This biotechnology company develops gene-edited disease resistance traits for seed companies and breeders to improve crop health and sustainability.